SACRAMENTO, Calif. — Dr. Timothy Albertson said Friday evening that he hopes COVID-19 patients at Sacramento’s University of California, Davis Medical Center will be willing to join a clinical trial of the experimental antibody cocktail that President Donald Trump said he’s taking to combat the disease.“There are trials where they focus on outpatients, and Dr. Stu Cohen (also with UCD) is involved in one of those trials where patients who have been exposed to family members or workers who have known disease can enroll in that trial,” Albertson said. “My trial with this drug is with patients wh...
